Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
BMC Infectious Diseases|October 13, 2023
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestationsBenedetta Varisco, Francesca Bai, Sara De Benedittis, et al.
The Journal of Infection|September 29, 2024
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron wavesValentina Mazzotta, Fulvia Mazzaferri, Simone Lanini, et al.
Journal of Virology|May 17, 2013
Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virusKazima Saira, Xudong Lin, Jay V DePasse, et al.
Journal of Medical Virology|October 3, 2022
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agentsValentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Nature Communications|August 22, 2022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIVAlessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 2, 2022
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysisIlaria Mastrorosa, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European CohortAnnegret Pelchen-Matthews, Álvaro H Borges, Joanne Reekie, et al.
Nature Communications|January 19, 2020
Machine learning can identify newly diagnosed patients with CLL at high risk of infectionRudi Agius, Christian Brieghel, Michael A Andersen, et al.
Vaccines|April 23, 2022
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19Antonella d'Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
BMC Infectious Diseases|October 13, 2023
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestationsBenedetta Varisco, Francesca Bai, Sara De Benedittis, et al.
The Journal of Infection|September 29, 2024
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron wavesValentina Mazzotta, Fulvia Mazzaferri, Simone Lanini, et al.
Journal of Virology|May 17, 2013
Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virusKazima Saira, Xudong Lin, Jay V DePasse, et al.
Journal of Medical Virology|October 3, 2022
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agentsValentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Nature Communications|August 22, 2022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIVAlessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 2, 2022
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysisIlaria Mastrorosa, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European CohortAnnegret Pelchen-Matthews, Álvaro H Borges, Joanne Reekie, et al.
Nature Communications|January 19, 2020
Machine learning can identify newly diagnosed patients with CLL at high risk of infectionRudi Agius, Christian Brieghel, Michael A Andersen, et al.
Vaccines|April 23, 2022
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19Antonella d'Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, et al.
Pageof 23